Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: Managed by watchful waiting

Journal of Lower Genital Tract Disease

Volumn 15, Issue 4, 2011, Pages 268-275

  Ho, Gloria Y F ^a   Einstein, Mark H ^b   Romney, Seymour L ^b   Kadish, Anna S ^b   Abadi, Maria ^b   Mikhail, Magdy ^c   Basu, Jayasri ^b   Thysen, Benjamin ^b   Reimers, Laura ^a   Palan, Prabhudas R ^c   Trim, Shelly ^a   Soroudi, Nafisseh ^a   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Department of Obstetrics and Gynecology ^*  (United States)

^c BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus

Indexed keywords

ASCORBIC ACID; FOLIC ACID;

ADULT; ARTICLE; CANCER GRADING; ERYTHROCYTE; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK BEHAVIOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; RISK FACTOR; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRAL GENETICS; WART VIRUS;

ADULT; ASCORBIC ACID; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLIC ACID; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WATCHFUL WAITING;

EID: 80053595947     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3182216fef     Document Type: Article

References (26)

1. Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113:18-25.
2. Bansal N, Wright JD, Cohen CJ, Herzog TJ. Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Res 2008;28:1763-6. (Pubitemid 351892881)
3. Fuchs K, Weitzen S, Wu L, Phipps MG, Boardman LA. Management of cervical intraepithelial neoplasia 2 in adolescent and young women. J Pediatr Adolesc Gynecol 2007; 20:269-74. (Pubitemid 47375138)
4. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007; 11:223-39. (Pubitemid 47530910)
5. Romney SL, et al. Effects of A-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 1997;65:483-92. (Pubitemid 27255993)
6. Burk RD, Kadish AS, Calderin S, Romney SL. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 1986;154:982-9. (Pubitemid 16085711)
7. Carreon JD, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol 2007;26:441-6. (Pubitemid 47476331)
8. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285:1500-5. (Pubitemid 32221899)
9. Behrens WA, Madere R. A highly sensitive high performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in the tissues, biological fluid, and foods. Anal Biochem 1987;165:102-7. (Pubitemid 17126170)
10. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital HPV infection in young women. J Infect Dis 1996;174:679-89. (Pubitemid 26325881)
11. Qu W, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-10. (Pubitemid 27216785)
12. Ho GYF, Studentsov YY, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004;13:110-6. (Pubitemid 38116628)
13. Studentsov YY, et al. Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus. J ClinMicrobiol 2002;40:1755-60. (Pubitemid 34493154)
14. Cornfield J. A method of estimating comparative rates from clinical data. Application to cancer of the lung, breast and cervix. J Natl Cancer Inst 1951;11:1269-75.
15. Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med 2008;65:501-6. (Pubitemid 351969703)
16. Bosch FX, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
17. Munoz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27. (Pubitemid 36159887)
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
19. Flatley JE, et al. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Cancer Epidemiol Biomarkers Prev 2009;18: 2782-9.
20. Ho GYF, et al. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998;78:594-9. (Pubitemid 28507183)
21. Giuliano AR, et al. Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. J Infect Dis 2003;188:1508-16. (Pubitemid 37523936)
22. Ho GYF, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
23. Remmink AJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306-11.
24. Khan MJ, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97:1072-9. (Pubitemid 41417924)
25. Rodriguez AC, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008;100:513-7.
26. Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003;188:1401-5. (Pubitemid 36741265)